Background Postoperative radioactive iodine (RAI) administration is widely utilized in
patients with differentiated thyroid cancer. While beneficial in select patients, it is critical to …

Follicular thyroid carcinoma (FTC) is the second most common cancer of the thyroid gland,
accounting for up to 20% of all primary malignant tumors in iodine-replete areas. The …

Radioactive iodine (RAI) is a key component in the treatment of differentiated thyroid cancer.
RAI has been recommended more selectively in recent years as guidelines evolve to reflect …

Introduction Survival rates in patients with non-medullary thyroid carcinoma (NMTC) are
high, increasing the possibility to develop a second malignant neoplasm (SMN). Many …

Objectives To establish an inflammation grading system for radioactive iodine‐induced
sialadenitis (RAIS) based on spiral computed tomography (CT), ultrasonography and …

Background The main basic aspects of the regulation of thyroid metabolism by iodine are
known, but given the complexity of the mechanisms involved, further analyzes in living …

The study of the human health effects of ionizing radiation (IR) is a dynamic and constantly
evolving enterprise. This flux is due largely to uncertainties inherent in appropriately …

Simple Summary Although the incidence of thyroid cancer is increasing, improvements in
treatment have resulted in more patients being confirmed to have a second primary cancer …

Follicular thyroid carcinoma (FTC) is the second most common cancer of the thyroid gland,
accounting for up to 20% of all primary malignant tumors in iodine-replete areas. The …

Objectives We aimed to evaluate the histopathological alterations in human salivary glands
after radioactive iodine (RAI) treatment for thyroid diseases. Study Design We retrospectively …